Pharmacogenomics and outcome of asthma: No clinical application for long-term steroid effects by CRHR1 polymorphisms

Journal of Allergy and Clinical Immunology

Volumn 121, Issue 6, 2008, Pages 1510-1513

  Dijkstra, Antoon ^a   Koppelman, Gerard H ^a   Vonk, Judith M ^b   Bruinenberg, Marcel ^b   Schouten, Jan P ^b   Postma, Dirkje S ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; FLUTICASONE; HISTAMINE; STEROID;

ADULT; ALLELE; ASTHMA; COHORT ANALYSIS; DISEASE EXACERBATION; DNA POLYMORPHISM; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HORMONE BINDING; HUMAN; LETTER; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MAST CELL DEGRANULATION; MEDICAL RECORD; OUTCOME ASSESSMENT; PHARMACOGENOMICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; DRUG RESISTANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RESPIRATORY FUNCTION TESTS;

EID: 44649117977     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.04.015     Document Type: Letter

References (9)

1. Tantisira K.G., Lake S., Silverman E.S., Palmer L.J., Lazarus R., Silverman E.K., et al. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Hum Mol Genet 13 (2004) 1353-1359
2. Weiss S.T., Lake S.L., Silverman E.S., Silverman E.K., Richter B., Drazen J.M., et al. Asthma steroid pharmacogenetics. A study strategy to identify replicated treatment responses. Proc Am Thorac Soc 1 (2004) 364-367
3. Xu J., Postma D.S., Howard T.D., Koppelman G.H., Zheng S.L., Stine O.C., et al. Major genes regulating total serum immunoglobulin E levels in families with asthma. Am J Hum Genet 67 (2000) 1163-1173
4. Agelaki S., Tsatsanis C., Gravanis A., and Margioris A.N. Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice. Infect Immun 70 (2002) 6068-6074
5. Theoharides T.C., Singh L.K., Boucher W., Pang X., Letourneau R., Webster E., et al. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 139 (1998) 403-413
6. Dijkstra A., Vonk J.M., Jongepier H., Koppelman G.H., Schouten J.P., ten Hacken N.H.T., et al. Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex. Thorax 61 (2006) 105-110
7. Jongepier H., Boezen H.M., Dijkstra A., Howard T.D., Vonk J.M., Koppelman G.H., et al. Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma. Clin Exp Allergy 34 (2004) 757-760
8. van Diemen C.C., Postma D.S., Vonk J.M., Bruinenberg M., Schouten J.P., and Boezen H.M. A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population. Am J Respir Crit Care Med 172 (2005) 329-333
9. Wechsler M.E. Managing asthma in the 21st century: role of pharmacogenetics. Pediatr Ann 35 (2006) 660-662 664-9